Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis. Wagner F, Mansfield JC, Lekkerkerker AN, Wang Y, et al. Gut 2023 Feb 2:gutjnl-2022-328387. doi: 10.1136/gutjnl-2022-328387.

Read + Share

Amedeo Smart

Independent Medical Education

Wagner F, Mansfield JC, Lekkerkerker AN, Wang Y, et al. Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis. Gut 2023 Feb 2:gutjnl-2022-328387. doi: 10.1136/gutjnl-2022-328387.
PMID: 36732049